Oscar Arrieta Selected Research

Appetite Stimulants

10/2022

Appetite stimulants for patients with cancer: current evidence for clinical practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oscar Arrieta Research Topics

Disease

87	Neoplasms (Cancer) 11/2022 - 04/2002
76	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 08/2008
30	Lung Neoplasms (Lung Cancer) 03/2022 - 08/2012
18	Adenocarcinoma of Lung 03/2022 - 05/2015
11	Disease Progression 01/2022 - 11/2011
9	Brain Neoplasms (Brain Tumor) 11/2022 - 06/2002
9	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2006
8	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2004
6	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 05/2002
5	Malnutrition (Nutritional Deficiencies) 11/2016 - 02/2010
5	Glioma (Gliomas) 09/2016 - 04/2002
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2022 - 01/2020
4	Pneumonia (Pneumonitis) 01/2022 - 01/2020
4	Malignant Mesothelioma 08/2021 - 05/2014
4	Melanoma (Melanoma, Malignant) 01/2021 - 05/2002
4	Meningioma (Meningiomas) 01/2019 - 06/2002
4	Adenocarcinoma 10/2018 - 08/2008
3	Anorexia 10/2022 - 09/2018
3	COVID-19 08/2022 - 11/2020
3	Inflammation (Inflammations) 01/2021 - 10/2004
3	Fatigue 12/2020 - 02/2010
3	Hypertension (High Blood Pressure) 01/2020 - 02/2005
3	Mesothelioma 11/2018 - 05/2014
3	Exanthema (Rash) 11/2016 - 06/2015
3	Heart Failure 07/2007 - 09/2003
3	Hepatocellular Carcinoma (Hepatoma) 02/2007 - 10/2006
2	Infections 08/2022 - 01/2005
2	Hypoxia (Hypoxemia) 02/2022 - 05/2014
2	Radiation Pneumonitis 01/2021 - 07/2009
2	Weight Loss (Weight Reduction) 01/2021 - 01/2007
2	Cachexia 01/2021 - 10/2018
2	Myasthenia Gravis 01/2021 - 05/2018
2	Diarrhea 12/2020 - 11/2016
2	Anemia 12/2020 - 02/2010
2	Carcinogenesis 01/2018 - 08/2012
2	Diabetes Mellitus 12/2016 - 07/2007

Drug/Important Bio-Agent (IBA)

21	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2008
16	Tyrosine Kinase InhibitorsIBA 01/2022 - 08/2008
14	Biomarkers (Surrogate Marker)IBA 06/2022 - 09/2003
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2007
12	PlatinumIBA 01/2020 - 03/2011
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2010
9	Docetaxel (Taxotere)FDA Link 01/2021 - 08/2014
7	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 07/2009
7	Paclitaxel (Taxol)FDA LinkGeneric 09/2016 - 02/2010
6	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 07/2018
6	SmokeIBA 11/2021 - 08/2008
5	Immune Checkpoint InhibitorsIBA 06/2022 - 09/2019
5	Metformin (Glucophage)FDA LinkGeneric 03/2022 - 12/2016
5	AfatinibIBA 03/2022 - 06/2015
5	Gemcitabine FDA Link 08/2021 - 07/2009
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2008
5	LigandsIBA 01/2021 - 10/2015
5	NivolumabIBA 01/2021 - 10/2015
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
4	Carcinoembryonic AntigenIBA 11/2021 - 04/2009
4	Bevacizumab (Avastin)FDA Link 09/2021 - 01/2016
4	AntibodiesIBA 01/2021 - 11/2017
4	Biological ProductsIBA 01/2021 - 10/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2007
4	RamucirumabIBA 10/2017 - 08/2014
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2016 - 06/2002
3	CrizotinibIBA 11/2022 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
3	Long Noncoding RNAIBA 01/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2016
3	CytokinesIBA 09/2018 - 02/2005
3	Nerve Growth Factor (NGF)IBA 09/2014 - 07/2008
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2014 - 07/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014 - 01/2005
3	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 04/2002
2	AntigensIBA 06/2022 - 10/2006
2	Nitroglycerin (Dynamite)FDA LinkGeneric 02/2022 - 05/2014
2	osimertinibIBA 01/2022 - 09/2021
2	Formaldehyde (Formol)FDA Link 12/2021 - 01/2016
2	ParaffinIBA 12/2021 - 01/2016
2	CarcinogensIBA 11/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2020
2	AsbestosIBA 01/2021 - 11/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2020
2	Gefitinib (Iressa)FDA Link 12/2020 - 09/2016
2	Colchicine FDA LinkGeneric 01/2020 - 10/2006
2	Vitamin A (Retinol)FDA LinkGeneric 01/2020 - 09/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2016
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2018 - 10/2017
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018 - 03/2016
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 08/2009
2	Estrogens (Estrogen)FDA Link 01/2018 - 07/2010
2	Peptides (Polypeptides)IBA 03/2016 - 07/2015

Therapy/Procedure

39	Therapeutics 10/2022 - 06/2002
29	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
15	Immunotherapy 06/2022 - 01/2012
13	Radiotherapy 06/2022 - 01/2007
4	Neoadjuvant Therapy 01/2020 - 01/2006
3	Chemoradiotherapy 01/2020 - 11/2011
2	Cranial Irradiation 01/2021 - 01/2021
2	Combined Modality Therapy 01/2021 - 07/2009
2	Aftercare (After-Treatment) 01/2020 - 01/2013